What is NDC 59651-327?

59651-327 is the product NDC for Phenoxybenzamine Hydrochloride, Phenoxybenzamine hydrochloride 10 mg/1 capsule, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Phenoxybenzamine Hydrochloride?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Phenoxybenzamine Hydrochloride NDC 59651-327

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-327Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0327Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-327-01	5965103270159651032701	100 CAPSULE in 1 BOTTLE (59651-327-01)Marketed from May 8, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phenoxybenzamine Hydrochloride
Generic name (nonproprietary): phenoxybenzamine hydrochloride
Active ingredients: Phenoxybenzamine hydrochloride — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215600
Marketing start: May 8, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 59651-327_3aeb0006-90e3-477a-9c81-0a8a671061d4SPL ID 3aeb0006-90e3-477a-9c81-0a8a671061d4SPL set ID 75f26681-a079-4ff3-9fff-75526041374cRxCUI 861402UNII X1IEG24OHL
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651032701 followed by a unit qualifier and the quantity

Package 59651-0327-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 16, 2024.

Indications (excerpt from the label)

INDICATION AND USAGE Phenoxybenzamine hydrochloride capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. If tachycardia is excessive, it may be necessary to use a beta -blocking agent concomitantly.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-327

What is NDC 59651-327?: 59651-327 is the product NDC for Phenoxybenzamine Hydrochloride, Phenoxybenzamine hydrochloride 10 mg/1 capsule, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Phenoxybenzamine Hydrochloride.
What is the active ingredient?: Phenoxybenzamine hydrochloride.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Phenoxybenzamine Hydrochloride?: 4 other product NDCs are listed under this name. See all Phenoxybenzamine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Phenoxybenzamine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
phenoxybenzamine hydrochloride	Phenoxybenzamine hydrochloride 10 mg/1	CapsuleOral	Rising Pharma Holdings, Inc.	16571-874	16571-0874-01
Phenoxybenzamine Hydrochloride	Phenoxybenzamine hydrochloride 10 mg/1	CapsuleOral	Burel Pharmaceuticals, LLC	35573-473	35573-0473-02
Phenoxybenzamine Hydrochloride	Phenoxybenzamine hydrochloride 10 mg/1	CapsuleOral	Novitium Pharma LLC	70954-365	70954-0365-10
Phenoxybenzamine hydrochloride	Phenoxybenzamine hydrochloride 10 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	60219-1502	60219-1502-01

Other NDCs under ANDA 215600

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215600
Product	Strength	Form · route	Labeler	Product NDC
Phenoxybenzamine Hydrochloride	Phenoxybenzamine hydrochloride 10 mg/1	CapsuleOral	Burel Pharmaceuticals, LLC	35573-473